THE OVERALL OBJECTIVE OF THIS CONTRACT IS TO ADVANCE THE DEVELOPMENT OF MONOVALENT VACCINES FOR PREVENTION OF MARBURG VIRUS (MARV) AND SUDAN EBOLAVIRUS (SUDV) DISEASE. THESE VACCINES ARE BASED ON RECOMBINANT EXPRESSION OF FILOVIRUS GLYCOPROTEINS IN

DEFINITIVE CONTRACT won by INTERNATIONAL AIDS VACCINE INITIATIVE INC. · work in NEW YORK, NY
$94,036,149
RecipientINTERNATIONAL AIDS VACCINE INITIATIVE INC. UEI ZEJBC8JQM3P5
Award ID75A50121C00077
Award amount$94,036,149
Award typeDEFINITIVE CONTRACT
Awarding agencyDepartment of Health and Human Services — Office of Assistant Secretary for Preparedness and Response
NAICS541714 — RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY)
PSCAN42
Start dateSep 30, 2021
End dateSep 29, 2026
Place of performanceNEW YORK, NY
Record updatedJun 25, 2024

View the official award record

Our catalog shows awards of $250K+ active within the last 5 years. Need older history or smaller awards? Tell us what you need — we expand by request.

Awards tell you who won. Bids tell you what's next. BidCatch scans 100+ federal, state, and local sources every night and sends the new opportunities matching your trade — before they're awarded to someone else. Free for 14 days, then $49.99/month.

Search open bids